Current Status and Progress in the Treatment of Lower Limb Lymphedema After Treatment of Gynecological Oncology.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
Read More Add to Saved list
  • Additional Information
    • Source:
      Publisher: Mary Ann Liebert, Inc Country of Publication: United States NLM ID: 101163587 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1557-8585 (Electronic) Linking ISSN: 15396851 NLM ISO Abbreviation: Lymphat Res Biol Subsets: MEDLINE
    • Publication Information:
      Original Publication: Larchmont, NY : Mary Ann Liebert, Inc., c2003-
    • Subject Terms:
      Genital Neoplasms, Female*/complications ; Genital Neoplasms, Female*/therapy ; Lymphedema*/diagnosis ; Lymphedema*/etiology ; Lymphedema*/therapy; Female ; Humans ; Lower Extremity ; Lymph Node Excision/adverse effects ; Quality of Life
    • Abstract:
      Purpose: To discuss the status and progress of treatment of lower limb lymphedema (LLL) after gynecological cancer treatment. Common gynecological malignancies include endometrial cancer, cervical cancer, ovarian cancer, and vulvar cancer. LLL is one of the common complications after gynecological cancer treatment. LLL is one of the common complications after gynecological cancer treatment, which seriously affects patients' quality of life. Methods: We searched the Medline database for literature on LLL after gynecological oncology treatment, reviewed the incidence and risk factors for LLL in different gynecological malignancies, and summarized advances in the prevention and treatment of LLL after gynecological malignancy treatment. Finally, we review data-based approaches for the treatment of LLL and discuss experimental therapies currently in development. Results: Treatment of LLL is usually combined, conservative, and surgical. Complete decongestive therapy is the gold standard for the treatment of LLL. Prevention and treatment of lymphedema of the lower extremities are important for patients with gynecological cancers. Conclusion: Clinicians should be aware of the prevention and treatment of LLL, with a precise diagnosis and effective intervention at an early stage to delay its progression and improve patients' quality of life.
    • Contributed Indexing:
      Keywords: complete decongestive therapy; gynecological oncology; lymphedema
    • Publication Date:
      Date Created: 20211026 Date Completed: 20220614 Latest Revision: 20220623
    • Publication Date:
      20240105
    • Accession Number:
      10.1089/lrb.2021.0035
    • Accession Number:
      34698556